Very long chain omega‐3 (n‐3) fatty acids and human health
- 28 August 2014
- journal article
- research article
- Published by Wiley in European Journal of Lipid Science and Technology
- Vol. 116 (10) , 1280-1300
Abstract
Omega‐3 (n‐3) fatty acids are a family of polyunsaturated fatty acids that contribute to human health and well‐being. Functionally the most important n‐3 fatty acids appear to be eicosapentaenoic acid (EPA) and docosahexaenoioc acid (DHA), but roles for n‐3 docosapentaenoic acid (DPA) are now emerging. Intakes of EPA and DHA are usually low, typically below recommended intakes. Increased intakes are reflected in greater incorporation into blood lipid, cell and tissue pools. Increased content of EPA and DHA modifies the structure of cell membranes and the function of membrane proteins involved as receptors, signaling proteins, transporters, and enzymes. EPA and DHA modify the production of lipid mediators and through effects on cell signaling can alter patterns of gene expression. Through these actions EPA and DHA alter cell and tissue responsiveness in a manner that seems to result in more optimal conditions for growth, development, and maintenance of health. The effects of n‐3 fatty acids are evident right through the life course, meaning that there is a need for all sectors of the population to have a sufficient intake of these important nutrients. EPA and DHA have a wide range of physiological roles which are linked to certain health or clinical benefits.Practical application: Very long chain omega‐3 (n‐3) fatty acids are found in seafood, especially fatty fish, and in supplements. They exert a range of health benefits as a result of their molecular, cellular and physiological actions. Consequently, very long chain n‐3 fatty acids play important roles in growth, development, optimal function, and maintenance of health and well‐being right across the life course. Therefore, all sectors of the population need to ensure sufficient intake of these important nutrients. This can be achieved through eating fatty fish or, failing that, use of good quality supplements.General overview of the mechanisms by which very long chain n‐3 fatty acids can influence the function of cells.Keywords
This publication has 206 references indexed in Scilit:
- Marine polyunsaturated fatty acids and cancer therapyBritish Journal of Cancer, 2013
- Omega 3 fatty acids and cognitive health in older peopleBritish Journal of Nutrition, 2012
- Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCTEuropean Journal of Clinical Nutrition, 2012
- Specialized pro-resolving lipid mediators in the inflammatory response: An updateBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer DiseaseJAMA, 2010
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing EffectsCell, 2010
- A Pilot Randomized Controlled Trial of Omega-3 Fatty Acids for Autism Spectrum DisorderJournal of Autism and Developmental Disorders, 2010
- Cardiovascular effects of marine omega-3 fatty acidsThe Lancet, 2010
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD StudyArchives of Neurology, 2006